900+ attendees in 2019

200+ Speakers

2019 Exhibition Sold Out

30+ Patients

89% Top 50 pharma confirmed in 2019

Our healthcare system is living on borrowed time. The only way forward is to build a new value-based healthcare model that’s fit for purpose, encouraging the development of treatments that push scientific boundaries and ensuring that patients will have affordable access. There are rare moments where everyone agrees change must come, and now that moment has arrived for healthcare those already working in Market Access must seize this opportunity. It will require a mindset change where pharma proactively engages payers, providers, patients, and even competitors, to create the new system that works for everyone.

A room full of great speakers and experts Regulatory Review Officer, FDA
Get the brochure

Market Access Speakers Include:

Mike SpencerVice President, Market Access Oncology

Mike Spencer

Muna BhanjiSenior Vice President, Global Market Access

Muna Bhanji

Robert DuboisExecutive Vice President and Chief Science Officer

Robert Dubois

Jeny McNairSenior Medical Director

Jeny McNair

Tamar ThompsonHead, Federal Payment Policy & State Government Affairs/Alliance Development

Tamar Thompson

Shontelle DodsonSenior Vice President, Healthcare Systems

Shontelle Dodson

The Key Market Access Themes 

Collaborate to innovate Engage payers, providers and patients to develop a system that benefits all

The value-based blueprint Speed up negotiations and engage payer needs with the essential framework for value-based contracts

Affordability first Develop innovative payment solutions that provide affordable access to life-changing treatments

More evidence = earlier access How RWE can unlock phase 2 access

New for 2019
Everything you need to know about eyeforpharma Philadelphia in 60 seconds

Josh Bramwell

Josh Bramwell
Head of Product

+44 (0) 207 375 7203

Izzy Gladstone

Izzy Gladstone
Head of Marketing

+1 347 458 1621

Michael Mayhew

Michael Mayhew
Global Project Director

+44 (0) 207 375 4335